An Open-label, Multicenter, Single-arm, Phase 4 Study of the Effect of Treatment with Velaglucerase alfa on Bone-related Pathology in Treatment-naive Patients with Type 1 Gaucher Disease
Clinical Trial Grant
Administered By
Pediatrics, Medical Genetics
Awarded By
Shire Human Genetics Therapies
Start Date
December 12, 2016
End Date
January 31, 2022
Administered By
Pediatrics, Medical Genetics
Awarded By
Shire Human Genetics Therapies
Start Date
December 12, 2016
End Date
January 31, 2022